Ok weekenders, let’s talk PMED. For the newbies in the room, PMED is PredictMedix Inc, a biotech company Equity Guru’s been working with for the past little bit. (Of…
Special Contributor
Two weeks ago, on Equity Guru’s Discord Channel, I mentioned this break of an important level on oil and provided these two target zones. We are rapidly approaching our…
The US Dollar is getting a lot of discussion in the financial media, in politics, by billionaires, and by a lot of market participants and fund managers. For good…
When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia. Neurodegenerative diseases,…
B.C. business leader Bryan Slusarchuk worked his way up from a golf caddy to a financier of major mining deals. His biggest triumph began in the mining downturn of 2014, when…
Industry insiders know it, and millennial spending patterns prove it: Big Tobacco and Big Alcohol are in trouble. Big Cannabis offers a more mindful recreational alternative – not to…
As the legalized cannabis market comes of age in North America and worldwide, the mainstream media tends to focus on cannabis growers and cultivators. While we wouldn’t discount the…
In the highly competitive global hemp-based skin-care market, businesses must strive to expand their reach into international markets. To this end, Yield Growth (BOSS.C) is looking beyond North America, with…
Heritage Cannabis (CANN.C), one of Canada’s fastest-growing vertically integrated marijuana providers, has just completed a bought deal offering of 32.66 million units of CANN shares. The company netted a…
IAnthus Capital (IAN.C) recently announced quarterly revenue of $2.2 million – $0.58 million lower than analysts’ expectations, though revenues increased 165% over the prior-year period. For the full year,…